Nonalcoholic Fatty Liver Disease Is Associated With Higher 1-year All-Cause Rehospitalization Rates in Patients Admitted for Acute Heart Failure

被引:19
|
作者
Valbusa, Filippo [1 ]
Bonapace, Stefano [2 ]
Grillo, Cristina [1 ]
Scala, Luca [1 ]
Chiampan, Andrea [2 ]
Rossi, Andrea [3 ]
Zoppini, Giacomo [4 ]
Lonardo, Amedeo [5 ]
Arcaro, Guido [1 ]
Byrne, Christopher D. [6 ,7 ]
Targher, Giovanni [4 ]
机构
[1] Sacro Cuore Hosp, Div Gen Med, Negrar, VR, Italy
[2] Sacro Cuore Hosp, Div Cardiol, Negrar, VR, Italy
[3] Univ & Azienda Osped Univ Integrata Verona, Dept Med, Cardiol Sect, Verona, Italy
[4] Univ & Azienda Osped Univ Integrata Verona, Dept Med, Sect Endocrinol Diabet & Metab, Piazzale Stefani 1, I-37126 Verona, Italy
[5] Azienda USL Modena, NOCSAE Baggiovara, Internal Med & Outpatient Liver Clin, Modena, Italy
[6] Univ Southampton, Fac Med, Nutr & Metab, Southampton SO9 5NH, Hants, England
[7] Univ Southampton, NIHR Biomed Res Ctr, Southampton, Hants, England
关键词
GAMMA-GLUTAMYL-TRANSFERASE; ATRIAL-FIBRILLATION; RENAL-FUNCTION; CARDIOVASCULAR-DISEASE; HOSPITALIZED-PATIENTS; RISK; COMPLICATIONS; DIAGNOSIS; NAFLD; DYSFUNCTION;
D O I
10.1097/MD.0000000000002760
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Repeat hospitalization due to acute heart failure (HF) is a global public health problem that markedly impacts on health resource use. Identifying novel predictors of rehospitalization would help physicians to determine the optimal postdischarge plan for preventing HF rehospitalization. Nonalcoholic fatty liver disease (NAFLD) is an emerging risk factor for many heart diseases, including HF. We assessed whether NAFLD at hospital admission predicts 1-year all-cause rehospitalization in patients with acute HF.We enrolled all patients consecutively admitted for acute HF to our General Medicine Division, from January 2013 to April 2014, after excluding patients with acute myocardial infarction, severe heart valve diseases, malignancy, known liver diseases, and those with volume overload related to extracardiac causes. NAFLD was diagnosed by ultrasonography and exclusion of competing etiologies. The primary outcome of the study was the 1-year all-cause rehospitalization rate.Among the 107 patients enrolled in the study, the cumulative rehospitalization rate was 12.1% at 1 month, 25.2% at 3 months, 29.9% at 6 months, and 38.3% at 1 year. Patients with NAFLD had markedly higher 1-year rehospitalization rates than those without NAFLD (58% vs 21% at 1 y; P<0.001 by the log-rank test). Cox regression analysis revealed that NAFLD was associated with a 5.5-fold increased risk of rehospitalization (adjusted hazard ratio 5.56, 95% confidence interval 2.46-12.1, P<0.001) after adjustment for multiple HF risk factors and potential confounders.In conclusion, NAFLD was independently associated with higher 1-year rehospitalization in patients hospitalized for acute HF.
引用
收藏
页数:7
相关论文
共 50 条
  • [11] Depression in nonalcoholic fatty liver disease and all-cause/cause-specific mortality
    Kim, Donghee
    Manikat, Richie
    Shaikh, Anjiya
    Cholankeril, George
    Ahmed, Aijaz
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023,
  • [12] Increased heart rate at hospital discharge augments 1-year rehospitalization rates, but does not affect two and three year rehospitalization rates in heart failure patients
    Yuksek, U.
    Akin, F.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1012 - 1012
  • [13] Association of platelet-to-lymphocyte ratio with 1-year all-cause mortality in ICU patients with heart failure
    Hu, Xinyu
    Cheng, Shijiao
    Du, Huaan
    Yin, Yuehui
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [14] Nonalcoholic fatty liver disease in early life and all-cause and cause-specific mortality
    Kim, Donghee
    Ahmed, Aijaz
    HEPATOBILIARY SURGERY AND NUTRITION, 2022, 11 (02) : 317 - 319
  • [15] Machine learning model for predicting 1-year and 3-year all-cause mortality in ischemic heart failure patients
    Cai, Anping
    Chen, Rui
    Pang, Chengcheng
    Liu, Hui
    Zhou, Yingling
    Chen, Jiyan
    Li, Liwen
    POSTGRADUATE MEDICINE, 2022, 134 (08) : 810 - 819
  • [16] Types of Physical Activity in Nonalcoholic Fatty Liver Disease and All-Cause and Cardiovascular Mortality
    Kim, Donghee
    Wijarnpreecha, Karn
    Dennis, Brittany B. B.
    Cholankeril, George
    Ahmed, Aijaz
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
  • [17] Gallstone Disease and Its Association With Nonalcoholic Fatty Liver Disease, All-Cause and Cause-Specific Mortality
    Konyn, Peter
    Alshuwaykh, Omar
    Dennis, Brittany B.
    Cholankeril, George
    Ahmed, Aijaz
    Kim, Donghee
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (04) : 940 - 948
  • [18] Circulating trimethylamine-N-oxide is associated with all-cause mortality in subjects with nonalcoholic fatty liver disease
    Flores-Guerrero, Jose L.
    Post, Adrian
    van Dijk, Peter R.
    Connelly, Margery A.
    Garcia, Erwin
    Navis, Gerjan
    Bakker, Stephan J. L.
    Dullaart, Robin P. F.
    LIVER INTERNATIONAL, 2021, 41 (10) : 2371 - 2382
  • [19] Predictors of heart failure readmission and all-cause mortality in patients with acute heart failure
    Espersen, Caroline
    Campbell, Ross T.
    Claggett, Brian L.
    Lewis, Eldrin F.
    Docherty, Kieran F.
    Lee, Matthew M. Y.
    Lindner, Moritz
    Brainin, Philip
    Biering-Sorensen, Tor
    Solomon, Scott D.
    McMurray, John J. V.
    Platz, Elke
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 406
  • [20] Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States
    Kim, Donghee
    Wijarnpreecha, Karn
    Sandhu, Keeryth K.
    Cholankeril, George
    Ahmed, Aijaz
    LIVER INTERNATIONAL, 2021, 41 (08) : 1832 - 1840